Results 1 to 10 of about 95,261 (258)

Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells [PDF]

open access: yesWorld Journal of Surgical Oncology, 2011
Introduction Bcl-xL, an important member of anti-apoptotic Bcl-2 family, plays critical roles in tumor progression and development. Previously, we have reported that overexpression of Bcl-xL was correlated with prognosis of colorectal cancer (CRC ...
Lv Chengyu   +5 more
doaj   +3 more sources

Relevance of Bcl-x expression in different types of endometrial tissues [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research, 2010
Objectives To explore the roles of Bcl-xl and Bcl-xs in the development and progression of endometrial carcinoma, and to analyze the correlation between Bcl-xl and Bcl-xs.
Li Yanxia   +4 more
doaj   +3 more sources

Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonism [PDF]

open access: yesNature Communications
BCL-xL promotes cell survival by binding BH3-only initiators through its hydrophobic groove. Combining resonance energy transfer assays and molecular dynamics simulations, we unravel that membrane anchoring of BCL-xL via its tail anchor selectively ...
Laurent Maillet   +8 more
doaj   +2 more sources

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress [PDF]

open access: yesNature Communications
BH3 mimetic drugs that inhibit BCL-2, BCL-XL, or MCL-1 have limited activity in solid tumors. Through assessment of xenograft-derived 3D prostate cancer models and cell lines we find that tumors with RB1 loss are sensitive to BCL-XL inhibition.
Andreas Varkaris   +31 more
doaj   +2 more sources

Targeting BCL-XL for degradation synergizes with gemcitabine against cholangiocarcinoma [PDF]

open access: yesBMC Medicine
Background Cholangiocarcinoma (CCA) remains a highly lethal malignancy with a dismal prognosis, primarily driven by therapeutic resistance. A dominant resistance mechanism involves overexpression of anti-apoptotic BCL-2 proteins (BCL-XL, BCL-2, MCL-1 ...
Qinghua Zeng   +13 more
doaj   +2 more sources

Evaluation of Bak and Bcl-Xl gene expression among pediatric patients with acute primary immune thrombocytopenia [PDF]

open access: yesClinical and Experimental Pediatrics
Background Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet counts and an increased risk of bleeding. Moreover, the apoptotic mechanisms of platelets may influence their production and lifespan.
Amira Zaki Badawy   +6 more
doaj   +2 more sources

Oxidative stress battles neuronal Bcl-xL in a fight to the death

open access: yesNeural Regeneration Research, 2021
Bcl-xL is a pro-survival protein of the Bcl2 family found in the mitochondrial membrane. Bcl-xL supports growth, development, and maturation of neurons, and it also prevents neuronal death during neurotoxic stimulation.
Han-A Park   +2 more
doaj   +1 more source

Bcl-xL Is Required by Primary Hippocampal Neurons during Development to Support Local Energy Metabolism at Neurites

open access: yesBiology, 2021
B-cell lymphoma-extra large (Bcl-xL) is a mitochondrial protein known to inhibit mitochondria-dependent intrinsic apoptotic pathways. An increasing number of studies have demonstrated that Bcl-xL is critical in regulating neuronal energy metabolism and ...
Joseph Jansen   +6 more
doaj   +1 more source

Bcl-XL inhibits membrane permeabilization by competing with Bax. [PDF]

open access: yesPLoS Biology, 2008
Although Bcl-XL and Bax are structurally similar, activated Bax forms large oligomers that permeabilize the outer mitochondrial membrane, thereby committing cells to apoptosis, whereas Bcl-XL inhibits this process. Two different models of Bcl-XL function
Lieven P Billen   +4 more
doaj   +1 more source

Ser14 phosphorylation of Bcl-xL mediates compensatory cardiac hypertrophy in male mice

open access: yesNature Communications, 2023
The anti-apoptotic function of Bcl-xL in the heart during ischemia/reperfusion is diminished by K-Ras-Mst1-mediated phosphorylation of Ser14, which allows dissociation of Bcl-xL from Bax and promotes cardiomyocyte death.
Michinari Nakamura   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy